🔗 Share this article

Texas Attorney General Paxton is suing the producers of acetaminophen, alleging the companies concealed potential risks that the pain reliever presented to children's neurological development.

The court filing arrives a month after Former President Trump advocated an unsubstantiated connection between using Tylenol - also known as acetaminophen - while pregnant and autism spectrum disorder in young ones.

The attorney general is suing the pharmaceutical giant, which formerly manufactured the medication, the only pain reliever approved for expectant mothers, and Kenvue, which now manufacturers it.

In a official comment, he said they "misled consumers by gaining financially from pain and pushing pills ignoring the risks."

The manufacturer says there is no credible evidence connecting Tylenol to autism.

"These companies lied for decades, intentionally threatening countless individuals to line their pockets," the attorney general, from the Republican party, declared.

The manufacturer commented that it was "deeply concerned by the dissemination of inaccurate information on the reliability of paracetamol and the likely effects that could have on the health of women and children in America."

On its official site, Kenvue also mentioned it had "regularly reviewed the pertinent research and there is no credible data that demonstrates a established connection between taking paracetamol and autism spectrum disorder."

Organizations representing physicians and health professionals agree.

ACOG has said paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to address pain and elevated temperature, which can pose significant medical dangers if not addressed.

"In over twenty years of investigation on the utilization of acetaminophen in pregnancy, no reliable research has successfully concluded that the consumption of acetaminophen in any trimester of pregnancy results in neurological conditions in offspring," the organization stated.

The lawsuit mentions recent announcements from the previous government in asserting the drug is allegedly unsafe.

In recent weeks, Trump caused concern from medical authorities when he told pregnant women to "fight like hell" not to consume Tylenol when ill.

The FDA then released a statement that doctors should consider limiting the consumption of Tylenol, while also stating that "a proven link" between the medication and autism spectrum disorder in children has not been established.

The Health Department head Kennedy, who supervises the Food and Drug Administration, had pledged in April to conduct "a massive testing and research effort" that would determine the source of autism spectrum disorder in a limited time.

But authorities advised that finding a sole reason of autism spectrum disorder - believed by scientists to be the outcome of a complex mix of inherited and environmental factors - would be difficult.

Autism is a form of permanent neurological difference and condition that influences how people experience and relate to the environment, and is recognized using physician assessments.

In his legal document, Paxton - aligned with the former president who is seeking federal office - asserts Kenvue and J&J "deliberately disregarded and attempted to silence the research" around acetaminophen and autism.

The lawsuit attempts to require the companies "remove any promotional materials" that asserts acetaminophen is secure for expectant mothers.

This legal action echoes the grievances of a collection of guardians of children with autism and attention deficit hyperactivity disorder who sued the producers of acetaminophen in recently.

A federal judge dismissed the legal action, declaring investigations from the plaintiffs' authorities was not conclusive.